On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases

In patients with inflammatory bowel diseases (IBD) undergoing biologic therapy, biomarkers of treatment response are still scarce. This study aimed to evaluate whether serum zonulin, a biomarker of intestinal permeability; soluble CD163 (sCD163), a macrophage activation marker; and a panel of serum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Caviglia, Gian Paolo, Rosso, Chiara, Stalla, Francesco, Rizzo, Martina, Massano, Alessandro, Abate, Maria Lorena, Olivero, Antonella, Armandi, Angelo, Vanni, Ester, Younes, Ramy, Fagoonee, Sharmila, Pellicano, Rinaldo, Astegiano, Marco, Saracco, Giorgio Maria, Bugianesi, Elisabetta, Ribaldone, Davide Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141255/
https://ncbi.nlm.nih.gov/pubmed/32183476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030800
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars